The global diagnostic electrophysiology catheter market was estimated to be worth around $2.1 billion in 2021 and is projected to grow at a CAGR of 5.9% to reach approximately $3.1 billion by the end of the forecast period.
Our research on the global diagnostic electrophysiology catheter market covered over 70 countries and employed a comprehensive methodology to assess market sizes, unit sales, company market shares, and produce precise forecasts.
The complete report on the global diagnostic electrophysiology (EP) catheter market encompasses conventional electrophysiology catheters, advanced electrophysiology catheters, and intracardiac echocardiography (ICE) catheters.
MARKET REPORT DATA TYPES INCLUDED:
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2028, and Historical Data to 2018
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
PROCEDURE NUMBERS
The number of diagnostic electrophysiology procedures was significantly affected by the COVID-19 pandemic in 2020, but was expected to fully recover in 2021 and reach the levels seen in 2019. Despite the drop and recovery in 2020 and 2021 due to the postponement and cancellation of elective procedures, the total number of diagnostic electrophysiology procedures is projected to grow at a mid to high-single digit rate throughout the forecast period.
GLOBAL DIAGNOSTIC ELECTROPHYSIOLOGY CATHETER MARKET TRENDS
In 2021, the EP lab system market grew from the previous year. This market encompasses both 3D mapping systems and EP recording systems. Over the forecast period, low single-digit growth is expected for EP recording devices and 3D mapping systems, as all existing EP labs already possess one of each of these devices.
GLOBAL DIAGNOSTIC ELECTROPHYSIOLOGY CATHETER MARKET SHARE INSIGHTS
The Global Diagnostic Electrophysiology Catheter Market has three main competitors: Biosense Webster, Abbott, and Boston Scientific. The leading competitor in the market was Biosense Webster. The company had the lead in the market because of the popularity of their AcuNav™ and CARTO® SOUNDSTAR® ultrasound catheters.
GLOBAL DIAGNOSTIC ELECTROPHYSIOLOGY CATHETER MARKET SEGMENTATION SUMMARY
- Conventional Electrophysiology Catheters
- Advanced Electrophysiology Catheters
- Intracardiac Echocardiography (ICE) Catheters
RESEARCH SCOPE SUMMARY
- Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
- Base Year: 2021
- Forecast: 2022-2028
- Historical Data: 2018-2021
- Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
- Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
- Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.
WHY CHOOSE IDATA?
- Experts Only - iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
- Global Coverage - iData's unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
- Attention to Detail - It's our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.